- call +1-201-465-4211
- email sales@mrinsights.biz
A preclinical CRO treatment is likely to offer the knowledge, experience, and skill needed to take a pharmaceutical medical device or product from the drawing board to distribution. The preclinical contract research organizations (CRO) sector has witnessed a period of tremendous development in the past, profiting from quickly growing (R&D) spending. Several pharmaceutical companies have lost revenue owing to growing patent expirations thus encouraging several manufacturers to outsource factors of the drug manufacturing method to CROs to decrease costs. Due to this, CROs are witnessing significant development.
Scope of the Report:
The worldwide market for Preclinical CRO is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Preclinical CRO in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Charles River Laboratories
Laboratory Corporation of America
Envigo
Eurofins Scientific
PRA Health Science
Wuxi AppTec
Medpace
Pharmaceutical Product Development
Paraxel
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Bioanalysis and DMPK Studies
Toxicology Testing
Others
Market Segment by Applications, can be divided into
Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies
There are 15 Chapters to deeply display the global Preclinical CRO market.
Chapter 1, to describe Preclinical CRO Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Preclinical CRO, with sales, revenue, and price of Preclinical CRO, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Preclinical CRO, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Preclinical CRO market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Preclinical CRO sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Preclinical CRO Introduction
1.2 Market Analysis by Type
1.2.1 Bioanalysis and DMPK Studies
1.2.2 Toxicology Testing
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Biopharmaceutical Companies
1.3.2 Government and Academic Institutes
1.3.3 Medical Device Companies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Charles River Laboratories
2.1.1 Business Overview
2.1.2 Preclinical CRO Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Charles River Laboratories Preclinical CRO Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Laboratory Corporation of America
2.2.1 Business Overview
2.2.2 Preclinical CRO Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Laboratory Corporation of America Preclinical CRO Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Envigo
2.3.1 Business Overview
2.3.2 Preclinical CRO Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Envigo Preclinical CRO Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eurofins Scientific
2.4.1 Business Overview
2.4.2 Preclinical CRO Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eurofins Scientific Preclinical CRO Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 PRA Health Science
2.5.1 Business Overview
2.5.2 Preclinical CRO Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 PRA Health Science Preclinical CRO Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Wuxi AppTec
2.6.1 Business Overview
2.6.2 Preclinical CRO Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Wuxi AppTec Preclinical CRO Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Medpace
2.7.1 Business Overview
2.7.2 Preclinical CRO Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Medpace Preclinical CRO Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Pharmaceutical Product Development
2.8.1 Business Overview
2.8.2 Preclinical CRO Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Pharmaceutical Product Development Preclinical CRO Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Paraxel
2.9.1 Business Overview
2.9.2 Preclinical CRO Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Paraxel Preclinical CRO Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Preclinical CRO Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Preclinical CRO Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Preclinical CRO Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Preclinical CRO Manufacturer Market Share in 2017
3.3.2 Top 6 Preclinical CRO Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Preclinical CRO Market Analysis by Regions
4.1 Global Preclinical CRO Sales, Revenue and Market Share by Regions
4.1.1 Global Preclinical CRO Sales and Market Share by Regions (2013-2018)
4.1.2 Global Preclinical CRO Revenue and Market Share by Regions (2013-2018)
4.2 North America Preclinical CRO Sales and Growth Rate (2013-2018)
4.3 Europe Preclinical CRO Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Preclinical CRO Sales and Growth Rate (2013-2018)
4.5 South America Preclinical CRO Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Preclinical CRO Sales and Growth Rate (2013-2018)
5 North America Preclinical CRO by Countries
5.1 North America Preclinical CRO Sales, Revenue and Market Share by Countries
5.1.1 North America Preclinical CRO Sales and Market Share by Countries (2013-2018)
5.1.2 North America Preclinical CRO Revenue and Market Share by Countries (2013-2018)
5.2 United States Preclinical CRO Sales and Growth Rate (2013-2018)
5.3 Canada Preclinical CRO Sales and Growth Rate (2013-2018)
5.4 Mexico Preclinical CRO Sales and Growth Rate (2013-2018)
6 Europe Preclinical CRO by Countries
6.1 Europe Preclinical CRO Sales, Revenue and Market Share by Countries
6.1.1 Europe Preclinical CRO Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Preclinical CRO Revenue and Market Share by Countries (2013-2018)
6.2 Germany Preclinical CRO Sales and Growth Rate (2013-2018)
6.3 UK Preclinical CRO Sales and Growth Rate (2013-2018)
6.4 France Preclinical CRO Sales and Growth Rate (2013-2018)
6.5 Russia Preclinical CRO Sales and Growth Rate (2013-2018)
6.6 Italy Preclinical CRO Sales and Growth Rate (2013-2018)
7 Asia-Pacific Preclinical CRO by Countries
7.1 Asia-Pacific Preclinical CRO Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Preclinical CRO Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Preclinical CRO Revenue and Market Share by Countries (2013-2018)
7.2 China Preclinical CRO Sales and Growth Rate (2013-2018)
7.3 Japan Preclinical CRO Sales and Growth Rate (2013-2018)
7.4 Korea Preclinical CRO Sales and Growth Rate (2013-2018)
7.5 India Preclinical CRO Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Preclinical CRO Sales and Growth Rate (2013-2018)
8 South America Preclinical CRO by Countries
8.1 South America Preclinical CRO Sales, Revenue and Market Share by Countries
8.1.1 South America Preclinical CRO Sales and Market Share by Countries (2013-2018)
8.1.2 South America Preclinical CRO Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Preclinical CRO Sales and Growth Rate (2013-2018)
8.3 Argentina Preclinical CRO Sales and Growth Rate (2013-2018)
8.4 Colombia Preclinical CRO Sales and Growth Rate (2013-2018)
9 Middle East and Africa Preclinical CRO by Countries
9.1 Middle East and Africa Preclinical CRO Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Preclinical CRO Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Preclinical CRO Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Preclinical CRO Sales and Growth Rate (2013-2018)
9.3 UAE Preclinical CRO Sales and Growth Rate (2013-2018)
9.4 Egypt Preclinical CRO Sales and Growth Rate (2013-2018)
9.5 Nigeria Preclinical CRO Sales and Growth Rate (2013-2018)
9.6 South Africa Preclinical CRO Sales and Growth Rate (2013-2018)
10 Global Preclinical CRO Market Segment by Type
10.1 Global Preclinical CRO Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Preclinical CRO Sales and Market Share by Type (2013-2018)
10.1.2 Global Preclinical CRO Revenue and Market Share by Type (2013-2018)
10.2 Bioanalysis and DMPK Studies Sales Growth and Price
10.2.1 Global Bioanalysis and DMPK Studies Sales Growth (2013-2018)
10.2.2 Global Bioanalysis and DMPK Studies Price (2013-2018)
10.3 Toxicology Testing Sales Growth and Price
10.3.1 Global Toxicology Testing Sales Growth (2013-2018)
10.3.2 Global Toxicology Testing Price (2013-2018)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2013-2018)
10.4.2 Global Others Price (2013-2018)
11 Global Preclinical CRO Market Segment by Application
11.1 Global Preclinical CRO Sales Market Share by Application (2013-2018)
11.2 Biopharmaceutical Companies Sales Growth (2013-2018)
11.3 Government and Academic Institutes Sales Growth (2013-2018)
11.4 Medical Device Companies Sales Growth (2013-2018)
12 Preclinical CRO Market Forecast (2018-2023)
12.1 Global Preclinical CRO Sales, Revenue and Growth Rate (2018-2023)
12.2 Preclinical CRO Market Forecast by Regions (2018-2023)
12.2.1 North America Preclinical CRO Market Forecast (2018-2023)
12.2.2 Europe Preclinical CRO Market Forecast (2018-2023)
12.2.3 Asia-Pacific Preclinical CRO Market Forecast (2018-2023)
12.2.4 South America Preclinical CRO Market Forecast (2018-2023)
12.2.5 Middle East and Africa Preclinical CRO Market Forecast (2018-2023)
12.3 Preclinical CRO Market Forecast by Type (2018-2023)
12.3.1 Global Preclinical CRO Sales Forecast by Type (2018-2023)
12.3.2 Global Preclinical CRO Market Share Forecast by Type (2018-2023)
12.4 Preclinical CRO Market Forecast by Application (2018-2023)
12.4.1 Global Preclinical CRO Sales Forecast by Application (2018-2023)
12.4.2 Global Preclinical CRO Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Preclinical CRO Picture
Table Product Specifications of Preclinical CRO
Figure Global Sales Market Share of Preclinical CRO by Types in 2017
Table Precl
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
